Should Scientists Budget Science?

When NAS’s Frank Press said yes, some science leaders balked WASHINGTON--National Academy of Sciences president Frank Press took an unusually bold plunge into dangerous waters last month by calling for a new approach to funding science. Instead of forcing Congress to choose from among a bewildering array of costly projects, Press told NAS members, scientists themselves should decide what’s best. Frank Press has suggested that federal funding of science be divided into three ca

Written byJeffrey Mervis
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

When NAS’s Frank Press said yes, some science leaders balked

WASHINGTON--National Academy of Sciences president Frank Press took an unusually bold plunge into dangerous waters last month by calling for a new approach to funding science. Instead of forcing Congress to choose from among a bewildering array of costly projects, Press told NAS members, scientists themselves should decide what’s best.

Frank Press has suggested that federal funding of science be divided into three categories. He says his priorities are based on a desire to "maintain American leadership in science and technology, and, steadily overcome the current national budget deficit." The following is reprinted from his NAS speech of April 26. To be funded now, with the highest priority, during a time of budgetary constraint when all agency budgets will be limited. 1.Preserving the human resource base and the pipeline for science and technology. This means absolute priority for training and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies